284 related articles for article (PubMed ID: 20527725)
1. Epigallocatechin-3-gallate (EGCG) downregulates gelatinase-B (MMP-9) by involvement of FAK/ERK/NFkappaB and AP-1 in the human breast cancer cell line MDA-MB-231.
Sen T; Dutta A; Chatterjee A
Anticancer Drugs; 2010 Jul; 21(6):632-44. PubMed ID: 20527725
[TBL] [Abstract][Full Text] [Related]
2. Multifunctional effect of epigallocatechin-3-gallate (EGCG) in downregulation of gelatinase-A (MMP-2) in human breast cancer cell line MCF-7.
Sen T; Moulik S; Dutta A; Choudhury PR; Banerji A; Das S; Roy M; Chatterjee A
Life Sci; 2009 Feb; 84(7-8):194-204. PubMed ID: 19105967
[TBL] [Abstract][Full Text] [Related]
3. Epigallocatechin-3-gallate (EGCG) downregulates EGF-induced MMP-9 in breast cancer cells: involvement of integrin receptor α5β1 in the process.
Sen T; Chatterjee A
Eur J Nutr; 2011 Sep; 50(6):465-78. PubMed ID: 21170718
[TBL] [Abstract][Full Text] [Related]
4. (-)-Epigallocatechin-3-gallate down-regulates EGFR, MMP-2, MMP-9 and EMMPRIN and inhibits the invasion of MCF-7 tamoxifen-resistant cells.
Farabegoli F; Papi A; Orlandi M
Biosci Rep; 2011 Apr; 31(2):99-108. PubMed ID: 20446926
[TBL] [Abstract][Full Text] [Related]
5. Culture of human breast cancer cell line (MDA-MB-231) on fibronectin-coated surface induces pro-matrix metalloproteinase-9 expression and activity.
Maity G; Choudhury PR; Sen T; Ganguly KK; Sil H; Chatterjee A
Tumour Biol; 2011 Feb; 32(1):129-38. PubMed ID: 20821288
[TBL] [Abstract][Full Text] [Related]
6. EGFR inhibition by (-)-epigallocatechin-3-gallate and IIF treatments reduces breast cancer cell invasion.
Farabegoli F; Govoni M; Spisni E; Papi A
Biosci Rep; 2017 Jun; 37(3):. PubMed ID: 28465354
[TBL] [Abstract][Full Text] [Related]
7. Laminin induces matrix metalloproteinase-9 expression and activation in human cervical cancer cell line (SiHa).
Maity G; Sen T; Chatterjee A
J Cancer Res Clin Oncol; 2011 Feb; 137(2):347-57. PubMed ID: 20425121
[TBL] [Abstract][Full Text] [Related]
8. (-)-Epigallocatechin-3-gallate inhibits invasion and migration of salivary gland adenocarcinoma cells.
Park JH; Yoon JH; Kim SA; Ahn SG; Yoon JH
Oncol Rep; 2010 Feb; 23(2):585-90. PubMed ID: 20043125
[TBL] [Abstract][Full Text] [Related]
9. (-)-Epigallocatechin 3-gallate inhibits invasion by inducing the expression of Raf kinase inhibitor protein in AsPC‑1 human pancreatic adenocarcinoma cells through the modulation of histone deacetylase activity.
Kim SO; Kim MR
Int J Oncol; 2013 Jan; 42(1):349-58. PubMed ID: 23135610
[TBL] [Abstract][Full Text] [Related]
10. (-)-Epigallocatechin-3-gallate promotes pro-matrix metalloproteinase-7 production via activation of the JNK1/2 pathway in HT-29 human colorectal cancer cells.
Kim M; Murakami A; Kawabata K; Ohigashi H
Carcinogenesis; 2005 Sep; 26(9):1553-62. PubMed ID: 15860507
[TBL] [Abstract][Full Text] [Related]
11. Epigallocatechin-3-gallate inhibits proliferation and migration of human colon cancer SW620 cells in vitro.
Zhou F; Zhou H; Wang T; Mu Y; Wu B; Guo DL; Zhang XM; Wu Y
Acta Pharmacol Sin; 2012 Jan; 33(1):120-6. PubMed ID: 22101170
[TBL] [Abstract][Full Text] [Related]
12. CADPE inhibits PMA-stimulated gastric carcinoma cell invasion and matrix metalloproteinase-9 expression by FAK/MEK/ERK-mediated AP-1 activation.
Han H; Du B; Pan X; Liu J; Zhao Q; Lian X; Qian M; Liu M
Mol Cancer Res; 2010 Nov; 8(11):1477-88. PubMed ID: 21047770
[TBL] [Abstract][Full Text] [Related]
13. Epigallocatechin-3-Gallate Inhibits Matrix Metalloproteinase-9 and Monocyte Chemotactic Protein-1 Expression Through the 67-κDa Laminin Receptor and the TLR4/MAPK/NF-κB Signalling Pathway in Lipopolysaccharide-Induced Macrophages.
Li YF; Wang H; Fan Y; Shi HJ; Wang QM; Chen BR; Khurwolah MR; Long QQ; Wang SB; Wang ZM; Wang LS
Cell Physiol Biochem; 2017; 43(3):926-936. PubMed ID: 28957799
[TBL] [Abstract][Full Text] [Related]
14. Association of suppression of extracellular signal-regulated kinase phosphorylation by epigallocatechin gallate with the reduction of matrix metalloproteinase activities in human fibrosarcoma HT1080 cells.
Maeda-Yamamoto M; Suzuki N; Sawai Y; Miyase T; Sano M; Hashimoto-Ohta A; Isemura M
J Agric Food Chem; 2003 Mar; 51(7):1858-63. PubMed ID: 12643642
[TBL] [Abstract][Full Text] [Related]
15. Fibronectin-integrin (alpha5beta1) modulates migration and invasion of murine melanoma cell line B16F10 by involving MMP-9.
Sil H; Sen T; Chatterjee A
Oncol Res; 2011; 19(7):335-48. PubMed ID: 21936403
[TBL] [Abstract][Full Text] [Related]
16. A splice variant of CD99 increases motility and MMP-9 expression of human breast cancer cells through the AKT-, ERK-, and JNK-dependent AP-1 activation signaling pathways.
Byun HJ; Hong IK; Kim E; Jin YJ; Jeoung DI; Hahn JH; Kim YM; Park SH; Lee H
J Biol Chem; 2006 Nov; 281(46):34833-47. PubMed ID: 16984917
[TBL] [Abstract][Full Text] [Related]
17. Epigallocatechin-3-gallate inhibits bladder cancer cell invasion via suppression of NF-κB‑mediated matrix metalloproteinase-9 expression.
Qin J; Wang Y; Bai Y; Yang K; Mao Q; Lin Y; Kong D; Zheng X; Xie L
Mol Med Rep; 2012 Nov; 6(5):1040-4. PubMed ID: 22941057
[TBL] [Abstract][Full Text] [Related]
18. Epigallocatechin-3-gallate decreases VEGF production in head and neck and breast carcinoma cells by inhibiting EGFR-related pathways of signal transduction.
Masuda M; Suzui M; Lim JT; Deguchi A; Soh JW; Weinstein IB
J Exp Ther Oncol; 2002; 2(6):350-9. PubMed ID: 12440226
[TBL] [Abstract][Full Text] [Related]
19. Green tea polyphenol epigallocatechin-3-gallate (EGCG) differentially inhibits interleukin-1 beta-induced expression of matrix metalloproteinase-1 and -13 in human chondrocytes.
Ahmed S; Wang N; Lalonde M; Goldberg VM; Haqqi TM
J Pharmacol Exp Ther; 2004 Feb; 308(2):767-73. PubMed ID: 14600251
[TBL] [Abstract][Full Text] [Related]
20. Lunasin suppresses the migration and invasion of breast cancer cells by inhibiting matrix metalloproteinase-2/-9 via the FAK/Akt/ERK and NF-κB signaling pathways.
Jiang Q; Pan Y; Cheng Y; Li H; Liu D; Li H
Oncol Rep; 2016 Jul; 36(1):253-62. PubMed ID: 27175819
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
